The Dana-Farber/Boston Children’s Cancer and Blood Disorders Center invites applications for the position of Clinical Director of the Pediatric Cellular Immunotherapy Program. The successful candidate will be responsible for leading the clinical research and clinical operational efforts necessary to bring CAR T-cells and other emerging cellular immunotherapies to pediatric and young adult patients with hematologic malignancies, solid tumors and brain tumors. Responsibilities will include leadership of a multidisciplinary clinical operations group and clinical research team, as well as development and oversight of a portfolio of clinical trials, including investigator-initiated, cooperative group and industry-sponsored protocols. The successful candidate will also be expected to collaborate with laboratory-based investigators in support of clinical trial development and correlative biology studies. Clinical responsibilities will include inpatient and outpatient care of pediatric cancer patients as well as consults for patients who may be appropriate for cellular immunotherapeutic approaches. Experience in the care of patients receiving CAR T-cells and other immunotherapies, as well as in clinical trial development/oversight and clinical operational administrative leadership are preferred.
Qualified candidates should have an MD degree and be board-certified in pediatric hematology-oncology. Dana-Farber and Boston Children’s Hospital are Harvard Medical School Teaching Hospitals. The chosen candidate may receive an academic appointment at the Assistant or Associate Professor rank at Harvard Medical School, commensurate with experience, accomplishments and teaching responsibilities.
The position will be based at the Dana-Farber Cancer Institute (an NCI-designated Comprehensive Cancer Center).
Salary offered will be consistent with fair market rate and commensurate with experience.
Interested candidates should submit a curriculum vitae and a statement of interest:
Scott A. Armstrong, M.D., Ph.D.
Department of Pediatric Oncology Dana Farber Cancer Institute
Vijay Sankaran, M.D., Ph.D.
Division of Hematology/Oncology, Boston Children's Hospital
c/o Tara Roderick
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law. Women and members of under-represented minorities are encouraged to apply.
Employer will assist with relocation costs.
Internal Number: CAR T Leader
About Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.
Dana-Farber Cancer Institute's ultimate goal is the eradication of cancer, AIDS, and related diseases and the fear that they engender.
Above all else, we make a difference by relieving the burden of disease now and for the future through our research, clinical care, education, outreach and advocacy.
We pursue excellence relentlessly and with integrity in all that we do, adhering always to the highest standards of conduct.
Compassion and respect
For thos...e in our care and for one another.
We foster the spirit of inquiry, promoting collaboration and innovation across traditional boundaries while celebrating individual creativity.